Literature DB >> 6099025

Nightly amended IRI/BG ratio in fasting test during sleeping periods in subjects with insulinoma and in normal, diabetic and obese subjects.

C Villaume, B Beck, J M Dollet, J P Pointel, P Drouin, G Debry.   

Abstract

In order to obtain a dynamic picture of the way abnormal insulinemia, as a function of blood glucose, occurs in the morning in subjects with insulinoma, we have measured amended plasma insulin (IRI)/blood glucose (BG) ratio during the fasting period of 4 sleeping subjects with insulinoma. Healthy subjects and subjects suffering from other diseases were used as reference in order to determine variations of this ratio during the night. BG and IRI were assayed at intervals of 15 or 30 min. Subjects with insulinoma differed from the other subjects by a very elevated ratio dispersion around the mean value with highly significant peaks (greater than 100). Mean value always remained outside the range (7-82) which covers the total range of values measured in healthy and pathological subjects.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6099025     DOI: 10.1007/bf02582085

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  14 in total

1.  Immunoassay of insulin with insulin-antibody precipitate.

Authors:  C N HALES; P J RANDLE
Journal:  Biochem J       Date:  1963-07       Impact factor: 3.857

2.  [The insulin-glucose ratio: its value in diagnosis of hypoglycemic islet cell tumors].

Authors:  N Linhart; G Strauch; P Moullé; L Leger
Journal:  Nouv Presse Med       Date:  1974-05-18

Review 3.  Progress report. Diagnosis of insulinoma.

Authors:  V Marks
Journal:  Gut       Date:  1971-10       Impact factor: 23.059

4.  Dextrose infusion by artificial pancreas in diagnosis of insulinoma.

Authors:  M Trovati; G Pagano; Q Cartia; R Lorenzati; F Cavalot; S Vitali; M T Caselle; G Lenti
Journal:  Lancet       Date:  1982-03-13       Impact factor: 79.321

5.  28-hour profiles of blood glucose (BG), plasma immunoreactive insulin (IRI) and IRI/BG ratio in four insulinomas.

Authors:  C Villaume; B Beck; J M Dollet; J P Pointel; P Drouin; G Debry
Journal:  Ann Endocrinol (Paris)       Date:  1984       Impact factor: 2.478

6.  Sleep: sequential reduction of paradoxical (REM) and elevation of slow-wave (NREM) sleep by a non-convulsive dose of insulin in rats.

Authors:  S Sangiah; D F Caldwell; M J Villeneuve; J J Clancy
Journal:  Life Sci       Date:  1982-08-23       Impact factor: 5.037

7.  Possible role of the CNS in regulating insulin secretion via humoral factors.

Authors:  E Bobbioni; B Jeanrenaud
Journal:  Int J Obes       Date:  1982

8.  Maintenance of basal plasma glucose and insulin concentrations in maturity-onset diabetes.

Authors:  R R Holman; R C Turner
Journal:  Diabetes       Date:  1979-03       Impact factor: 9.461

9.  Nervous regulation of insulin release by the intestinal vagal glucoreceptors.

Authors:  N Mei; A Arlhac; A Boyer
Journal:  J Auton Nerv Syst       Date:  1981-11

10.  Neuroendocrine control of basal insulin secretion in man: a study with bromocriptine, clonidine and naloxone.

Authors:  G A Zampa; F Benfenati; E Ghisoli; G Corbucci; P Vecchi; I Zini; N Battistini; L F Agnati
Journal:  J Endocrinol Invest       Date:  1981 Oct-Dec       Impact factor: 4.256

View more
  1 in total

Review 1.  Insulinoma Masquerading as Rapid Eye Movement Sleep Behavior Disorder: Case Series and Literature Review.

Authors:  Keisuke Suzuki; Akiko Kawasaki; Masayuki Miyamoto; Tomoyuki Miyamoto; Takashi Kanbayashi; Masatoshi Sato; Tetsuo Shimizu; Koichi Hirata
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.